Dr. Zhang, PhD (@CureFinder) header
Dr. Zhang, PhD (@CureFinder) profile picture

Cancer immunologist challenging conventional thinking on advanced cancer. Targeting #cancer cachexia to help patients survive.

Joined January 2021
Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)Photo by Dr. Zhang, PhD (@CureFinder)
My book is out. When the Body Turns Against Itself: A Patient's Guide to Cancer Cachexia. Plain language. No jargon. Honest about what we know and what we don't. For every family watching a loved one waste away. amazon.com/dp/B0HKWZLF7P
3
3
8
498
The track record is sobering: appetite stimulants, ghrelin agonists, single cytokine blockers, anabolics. None delivered lasting functional or survival benefit. My read: they all aimed at one molecule while the disease is a whole-system disorder.
1
1
97
This review I wrote with a Stanford collaborator. Its question: why has decades of cachexia drug development failed — and what should the field do instead?
3
195
If a broad immune correction worked in the lab, the bigger question is why cachexia drugs have failed patients for decades. Next week's paper — written with a Stanford collaborator — is our answer.
1
3
173
Why R-ketorolac? It's one mirror-image half of the familiar painkiller ketorolac — the half our program developed as an immunomodulator. Same starting molecule, different job: correcting an immune disorder, not killing pain.
3
205